Tumor budding as a strong prognostic indicator in invasive ampullary Adenocarcinomas Journal Article


Authors: Ohike, N.; Coban, I.; Kim, G. E.; Basturk, O.; Tajiri, T.; Krasinskas, A.; Bandyopadhyay, S.; Morohoshi, T.; Shimada, Y.; Kooby, D. A.; Staley, C. A.; Goodman, M.; Volkan Adsay, N.
Article Title: Tumor budding as a strong prognostic indicator in invasive ampullary Adenocarcinomas
Abstract: Prognostication of invasive ampullary adenocarcinomas (AACs) and their stratification into appropriate management categories have been highly challenging owing to a lack of well-established predictive parameters. In colorectal cancers, recent studies have shown that tumor budding confers a worse prognosis and correlates significantly with nodal metastasis and recurrence; however, this has not been evaluated in AAC.To investigate the prevalence, significance, and clinical correlations of tumor budding in AAC, 244 surgically resected, stringently defined, invasive AAC were analyzed for tumor budding - -defined as the presence of more than or equal to 5 isolated single cancer cells or clusters composed of fewer than 5 cancer cells per field measuring 0.785mm using a 20× objective lens in the stroma of the invasive front. The extent of the budding was then further classified as "high" if there were greater than or equal to 3 budding foci and as "low" if there were <3 budding foci or no budding focus.One hundred ninety-four AACs (80%) were found to be high-budding and 50 (20%) were low-budding. When the clinicopathologic features and survival of the 2 groups were compared, the AACs with high-budding had larger invasion size (19mm vs. 13mm; P<0.001), an unrecognizable/absent preinvasive component (57% vs. 82%; P<0.005), infiltrative growth (51% vs. 2%; P<0.001), nonintestinal-type histology (72% vs. 46%; P<0.001), worse differentiation (58% vs. 10%; P<0.001), more lymphatic (74% vs. 10%; P<0.001), and perineural invasion (28% vs. 2%; P<0.001); more lymph node metastasis (44% vs. 17%; P<0.001), higher T-stage (T3 and T4) (42% vs. 10%; P<0.001), and more aggressive behavior (mean survival: 50mo vs. 32mo; 3-year and 5-year survival rates: 93% vs. 41% and 68% vs. 24%, respectively; P<0.001). Furthermore, using a multivariable Cox regression model, tumor budding was found to be an independent predictor of survival (P=0.01), which impacts prognosis (hazard ratio: 2.6) even more than T-stage and lymph node metastasis (hazard ratio: 1.9 and 1.8, respectively).In conclusion, tumor budding is frequently encountered in AAC. High-budding is a strong independent predictor of overall survival, with a prognostic correlation stronger than the 2 established parameters: T-stage and lymph node metastasis. Therefore, budding should be incorporated into surgical pathology reports for AAC. © 2010 by Lippincott Williams & Wilkins.
Keywords: adult; aged; aged, 80 and over; middle aged; survival rate; clinical trial; mortality; united states; lymph node metastasis; lymphatic metastasis; adenocarcinoma; metastasis; pathology; cancer invasion; multicenter study; carcinoma; neoplasm invasiveness; budding; tumor; vater papilla; precancerous conditions; bile duct tumor; ampulla of vater; common bile duct neoplasms; precancer; ampulla; ampullary; prognostic parameter
Journal Title: American Journal of Surgical Pathology
Volume: 34
Issue: 10
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2010-10-01
Start Page: 1417
End Page: 1424
Language: English
DOI: 10.1097/PAS.0b013e3181f0b05a
PUBMED: 20871215
PROVIDER: scopus
PMCID: PMC3163902
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: AJSPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Olca Basturk
    352 Basturk